This brand name is authorized in Ecuador, Hong Kong SAR China, Mexico.
The drug DANZEN contains one active pharmaceutical ingredient (API):
1
|
UNII
NL053ABE4J - SERRAPEPTASE
|
|
Serrapeptase suppresses fibrinolytic activity and increased vascular permeability, suppresses edema of inflammation, strongly hydrolyzes bradykinin and cleaves fibrin and fibrinogen without affecting proteins. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 2996-MEE-0917, 3046-MEE-1017 |
| HK | Department of Health Drug Office | 33513 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 76248 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.